首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1392342

全球遺傳檢測市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Hereditary Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年11月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2030 年，全球遺傳檢測市場的市場規模將從 2022 年的 76.3 億美元達到近 156.6 億美元，2023-2030 年研究期間CAGR為 9.4%。

遺傳測試是為了識別特定基因組序列中特定基因的存在而進行的測試。基因可以透過定序直接鑑定或透過各種方法間接鑑定。遺傳檢測可以揭示可能導致疾病的基因變化（突變）。遺傳檢測在確定某些疾病的風險、篩檢，有時甚至是醫療方面發揮著至關重要的作用。

市場動態：

不斷成長的老年人口使人們更容易患慢性病，這增加了對預防性診斷，特別是遺傳性檢測的需求。此外，技術的不斷進步為市場擴張提供了一些機會。為利基治療領域開發客製化檢測試劑盒有助於市場的快速成長。此外，各國政府越來越注重監管和提高人們對遺傳檢測的認知，導致這些檢測在世界各地得到更快的採用。可能擴大遺傳檢測市場規模的另一個重要因素是對個人化藥物的需求不斷成長。然而，對基於遺傳檢測的診斷標準化和嚴格的產品核准程序的擔憂預計將阻礙遺傳檢測市場的擴張。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球遺傳檢測市場的各個細分市場進行了包容性評估。遺傳檢測產業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲遺傳檢測市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。遺傳檢測市場的主要參與者包括 Myriad Genetics Inc.、Invitae Corporation、Illumina, Inc.、Natera, Inc.、Laboratory Corporation of America Holdings、F. Hoffmann-La Roche Ltd、Quest Diagnostics Incorporated、CooperSurgical Inc.、Agilent Technologies Inc.、Thermo Fisher Scientific, Inc. 及其他本部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他開發。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：遺傳檢測市場公司的競爭格局

基因檢測市場市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Myriad Genetics Inc.

公司簡介
公司收入
產品
最近的發展

Invitae Corporation

公司簡介
公司收入
產品
最近的發展

Illumina Inc.

公司簡介
公司收入
產品
最近的發展

Natera Inc.

公司簡介
公司收入
產品
最近的發展

Laboratory Corporation of America Holdings

公司簡介
公司收入
產品
最近的發展

F. Hoffmann-La Roche Ltd

公司簡介
公司收入
產品
最近的發展

Quest Diagnostics Incorporated

公司簡介
公司收入
產品
最近的發展

Coopersurgical Inc.

公司簡介
公司收入
產品
最近的發展

Agilent Technologies Inc.

公司簡介
公司收入
產品
最近的發展

Thermo Fisher Scientific Inc

公司簡介
公司收入
產品
最近的發展

其他
- 公司簡介
- 公司收入
- 產品
- 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR11218545

The global demand for Hereditary Testing Market is presumed to reach the market size of nearly USD 15.66 BN by 2030 from USD 7.63 BN in 2022 with a CAGR of 9.4% under the study period 2023 - 2030.

Hereditary testing is a test performed to identify a particular gene's presence within a particular genome sequence. The genes can be identified directly through sequencing or indirectly via various methods. Hereditary testing can reveal changes (mutations) in the genes that may cause illness or disease. Hereditary testing plays a vital role in determining the risk of developing certain diseases, screening, and sometimes medical treatment.

MARKET DYNAMICS:

The growing geriatric population makes people more susceptible to chronic diseases, which increases the demand for preventive diagnostics, particularly hereditary testing. Moreover, the increasing technological advancements have opened several opportunities for market expansion. Developing customized testing kits for niche therapeutic areas is assisting the market's rapid growth. Furthermore, governments' increasing focus on regulating and creating awareness regarding hereditary tests has resulted in faster adoption of these tests around the world. Another important factor that could increase the size of the hereditary testing market is the growing need for personalized medication. However, worries over the standardization of hereditary testing-based diagnoses and tight product approval procedures are projected to hamper the hereditary testing market's expansion.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hereditary testing. The growth and trends of hereditary testing industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the hereditary testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Hereditary Cancer Testing
Hereditary Non-cancer Testing

By Technology

Cytogenetic
Biochemical
Molecular Testing

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Hereditary Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hereditary testing market include Myriad Genetics Inc., Invitae Corporation, Illumina, Inc., Natera, Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, CooperSurgical Inc., Agilent Technologies Inc., Thermo Fisher Scientific, Inc. and Others This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . HEREDITARY TESTING MARKET - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL HEREDITARY TESTING MARKET MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Hereditary Cancer Testing Historic and Forecast Sales by Regions
6.5 Hereditary Non-cancer Testing Historic and Forecast Sales by Regions

7 . GLOBAL HEREDITARY TESTING MARKET MARKET ANALYSIS BY TECHNOLOGY

7.1 Overview by Technology
7.2 Historical and Forecast Data
7.3 Analysis by Technology
7.4 Cytogenetic Historic and Forecast Sales by Regions
7.5 Biochemical Historic and Forecast Sales by Regions
7.6 Molecular Testing Historic and Forecast Sales by Regions

8 . GLOBAL HEREDITARY TESTING MARKET MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE HEREDITARY TESTING MARKET COMPANIES

9.1. Hereditary Testing Market Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF HEREDITARY TESTING MARKET INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Myriad Genetics Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Invitae Corporation
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Illumina Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Natera Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Laboratory Corporation of America Holdings
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. F. Hoffmann-La Roche Ltd
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Quest Diagnostics Incorporated
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Coopersurgical Inc.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Agilent Technologies Inc.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Thermo Fisher Scientific Inc
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. Others
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments